Live news related to SPIE stock (FR0012757854): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on SPIE mainly cover analyst notes, M&A activity et the annual general meeting. The stock trades at €43,60 on Euronext Paris, up 0,83% at the last update. This page lists the articles published on SPIE stock to track the share price, company announcements and any item likely to influence market perception.
The multi-technical services specialist closed the session lower, in a SBF 120 also oriented downward. The stock has been evolving for several weeks b…
Spie is regaining ground this Friday, in an SBF 120 also oriented upward. The share of the multi-technical services specialist is benefiting from a fa…
Pressure is intensifying on the multi-technical services specialist's stock, which extends its decline in a European market globally oriented downward…
The multi-technical services specialist's share is resisting the general trend on Tuesday, advancing significantly in an SBF 120 that is losing ground…
Selling pressure intensifies on the multi-technical services specialist's stock during a difficult session for the SBF 120. The decline occurs as the …
In a stable SBF 120 this Wednesday morning, SPIE stands out with a gain of nearly 2% during the session, ranking among the index's best performers. Th…
The stock of the multi-technical services specialist in energy and communications sharply rebounds mid-morning at the Paris Stock Exchange, within a b…
The stock of the multi-technical services specialist in energy and communications is declining in the Paris market, which is also trending downward. T…
Shares of the multi-technical services specialist in energy and communications significantly dropped during the session, amidst a weakened CAC 40 due …
SPIE has recently announced the acquisition of Nimeg AG, a Swiss engineering and project management specialist in GMP environments for the pharmaceuti…
